PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Symptom | |diabetes |
| Sentences | 526 |
| PubMedID- 24379686 | Dyslipidemia, an established risk factor for cardiovascular disease, is common in patients with type 2 diabetes, affecting almost 50% of this population. |
| PubMedID- 25238222 | What is it about very low density lipoproteins (vldl) and cardiovascular disease in patients with type 2 diabetes mellitus: is it the triglycerides or the cholesterol. |
| PubMedID- 21501602 | Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus. |
| PubMedID- 25881261 | Foot ischemia in patients with diabetes may be attributed to atherosclerotic macrovascular disease and additional microcirculatory dysfunction. |
| PubMedID- 26097512 | Obesity itself has been shown to predispose an individual to hypertension and cardiovascular disease . |
| PubMedID- 24533664 | Among individuals with established diabetes, risk of cardiovascular disease and mortality can be reduced by intensive treatment of multiple risk factors, including blood pressure, cholesterol and glucose, although there remains some uncertainty about the merits of tight glycaemic control. |
| PubMedID- 24443675 | Brain abnormalities such as white matter lesions (wmls) are not only linked to cerebrovascular disease, but also with normal aging, diabetes and other conditions increasing the risk for cerebrovascular pathologies. |
| PubMedID- 24623985 | Macrovascular disease in diabetes corresponds to the atherosclerotic damage in the blood vessels, which limits blood flow to the penis. |
| PubMedID- 21257100 | Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus. |
| PubMedID- 21767347 | Background: the aim of the present study was to examine trends in the control of key risk factors for cardiovascular disease among adults with diagnosed diabetes in the us from 1999 to 2008. |
| PubMedID- 24278703 | Finally, the results of the accord trial showed that the combination of fenofibrate and simvastatin does not reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus, as compared with statin monotherapy ; only subgroups of patients with dyslipidemia seem to benefit from fibrate therapy. |
| PubMedID- 21785619 | A therapeutic effect of myricetin in patients with cardiovascular diseases associated with diabetes mellitus has also been reported . |
| PubMedID- 24499591 | Even though the between-group differences in crp in the present study were small, and crp has been used as a consistent marker for evaluating the extent of cardiovascular diseases in subjects with type 1 diabetes , we suggest that others determinants, such as genetic predisposition, coping mechanisms, and environmental factors, make individuals more susceptible to changes in this inflammatory marker. |
| PubMedID- 23385371 | While some authorities, primarily those funded by the food industry, have argued that the high amounts of added sugars in food and beverages may contribute to health risks solely as a consequence of their caloric content, there is also mounting evidence that fructose may have a specific ability to cause fatty liver (which can progress to cirrhosis of the liver), high triglycerides in blood (which can contribute to cardiovascular disease), insulin resistance (leading to type 2 diabetes) and increased appetite (which obviously can lead to obesity) . |
| PubMedID- 22301118 | Although identification can be useful, there are no studies showing that screening alone improves depressive symptoms and cardiac outcomes (37) or diabetes outcomes (38) in patients with cardiovascular disease or diabetes, respectively. |
| PubMedID- 21854817 | Subjects with diabetes mellitus, evidence of myocardial infarction or cerebrovascular disease were excluded from the study. |
| PubMedID- 23396240 | This paper examines the usefulness of several noninvasive imaging techniques to study cardiovascular diseases in individuals with diabetes mellitus, with emphasis on nuclear cardiology, and proposes a diagnostic algorithm for detection of silent ischemia. |
| PubMedID- 24624891 | Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (riace) italian multicenter study. |
| PubMedID- 23185202 | Cardiovascular disease is common in patients with diabetes mellitus and related clinical outcomes are worse compared with non-diabetics. |
| PubMedID- 20500877 | An inverse association between weight and adiponectin level has been found and low plasma-adiponectin levels are considered to be a predictor of cardiovascular disease in patients with type 2 diabetes . |
| PubMedID- 22375126 | Participants were excluded if they failed a screening cardiac stress test, had type 1 diabetes, had a history of major cardiovascular disease, had orthopedic or rheumatologic problems that impeded exercise, and/or started or changed cholesterol drug use within the previous 3 months. |
| PubMedID- 24779961 | Moreover, circulating levels of tnfr2 predict morbidities such as cardiovascular disease and nephropathy in patients with type 2 diabetes (14,15). |
| PubMedID- 23715623 | Although insulin injections can provide good glycemic control, many patients with type 1 diabetes still have complications of hyperglycemia, including cardiovascular disease, retinopathy, and neuropathy. |
| PubMedID- 21772665 | Diabetic cardiomyopathy entails the cardiac injury induced by diabetes independently of any vascular disease or hypertension. |
| PubMedID- 21390057 | Pulse pressure and systolic night-day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 20701768 | Risk factor reduction is the most important therapy for primary and secondary prevention of macrovascular disease in patients with and without diabetes mellitus. |
| PubMedID- 25109981 | Although there is substantial evidence linking diabetes with cardiovascular disease, the specific effect of hyper- (or hypo-) glycaemia is less well understood. |
| PubMedID- 23849306 | Table 3.relationship between plasma fgf-23 concentrations and change in left ventricular ejection fraction during follow-up in chronic dialysis patients.modelfgf-23 tertiles (ru/ml) difference (95% ci)log10 fgf-23 difference (95% ci)≤ 1,9661,967 – 11,492> 11,492unadjusted0.0 (ref)–1.0 (–7.2 to 5.2)–6.7 (–13.1 to –0.33)–4.3 (–9.3 to 0.66)model 10.0 (ref)0.13 (–6.6 to 6.9)–8.0 (–15.5 to –0.53)–6.5 (–11.3 to –1.73)model 20.0 (ref)0.12 (–6.8 to 7.0)–8.4 (–16.2 to –0.62)–7.2 (–12.3 to –2.1)model 1: adjusted for age, gender, race, diabetes, hypertension, history of cardiovascular disease, body mass index, systolic blood pressure, serum albumin, hemoglobin, phosphorus, plasma 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d. model 2: adjusted for covariates in model 1 plus use of angiotensin converting enzyme inhibitors, angiotensin receptor blockers and β-blockers. |
| PubMedID- 25288671 | We hypothesized that preexisting brain microvascular disease in patients with diabetes might partly explain increased stroke severity and impact on outcome. |
| PubMedID- 23264288 | After full-text review of 33 articles, 15 studies were excluded because they were missing sufficient data, did not report rr or hr estimates, and assessed cardiovascular disease with type 2 diabetes or genetic variants of crp. |
| PubMedID- 23922510 | Epidemiological analysis and randomized clinical trials have shown the impact of high blood pressure as risk factors for microvascular and macrovascular disease in patients with diabetes (29). |
| PubMedID- 21080740 | There was a beneficial effect of intensive glucose control on cardiovascular disease in patients with type 1 diabetes in only one trial. |
| PubMedID- 25466521 | The differences between relative risks of different cardiovascular diseases in patients with type 2 diabetes have implications for clinical risk assessment and trial design. |
| PubMedID- 25285121 | He did not have diabetes or history of peripheral vascular disease. |
| PubMedID- 23748249 | Among japanese who consume rice as a major staple food, dietary strategies that prevent type 2 diabetes without increasing risk of cardiovascular disease might need to be explored. |
| PubMedID- 21625418 | The goal for non-hdl cholesterol has been reported to be the level of ldl cholesterol plus 30 mg/dl.36 in type 2 diabetics, several characteristics such as elevated triglycerides, decreased hdl cholesterol, and elevated small dense ldl, are well-known.25 because non-hdl cholesterol reflects all apolipoprotein b-containing atherogenic lipoproteins, non-hdl cholesterol may be useful in predicting cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 23410093 | We were also able to characterize several biological determinants in the association between depression and cardiovascular disease in individuals with diabetes, including measures of hpa axis activity (i.e. |
| PubMedID- 22108456 | However, the underlying mechanisms linking type 2 diabetes with cardiovascular disease remain poorly understood. |
| PubMedID- 22762006 | Hypertension (htn), obesity, hyperlipidemia, and cigarette smoking act as independent modifiable contributors to cardiovascular disease (cvd) in patients with diabetes 3. |
| PubMedID- 23466074 | Role of relationship between hba1c, fibrinogen and hdl-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 21297971 | Endothelial dysfunction is an important defect that contributes to erectile dysfunction and vascular disease in diabetes and is associated with insulin resistance . |
| PubMedID- 20920271 | However, with the occurrence of dysfunction, the endothelium is a potential contributor to the pathogenesis of vascular disease in diabetes mellitus and atherosclerosis . |
| PubMedID- 26419903 | Similarly, the findings of collaborative meta-analysis of 102 prospective studies reported a twofold higher risk for a wide range of vascular diseases in people with diabetes in comparison with those without diabetes mellitus . |
| PubMedID- 22162800 | There is growing body of evidence linking non-brain microvascular complications with cerebrovascular disease findings in patients with diabetes . |
| PubMedID- 20822519 | Contradictory results have also been published regarding the role of fetuin-a in macrovascular disease and patients with type 2 diabetes . |
| PubMedID- 20978091 | Insulin resistance predicts the extent of coronary artery calcification and may contribute to the increased risk of cardiovascular disease in patients with type 1 diabetes as well as subjects without diabetes. |
| PubMedID- 25887356 | Objective: despite its growing prevalence in china, the extent to which diabetes leads to excess cardiovascular disease (cvd) mortality and all-cause mortality is unclear. |
| PubMedID- 26116592 | Plasma adiponectin levels inversely correlate to clinical parameters in type 2 diabetes mellitus patients with macrovascular diseases. |
| PubMedID- 22291824 | We assessed the long-term effects of multifactorial intervention on lfts and their association with cardiovascular disease (cvd) events in patients with mets without diabetes mellitus or cvd. |
| PubMedID- 25849735 | Moderately increased albuminuria, which was formerly called microalbuminuria and has been described as an early diagnostic marker of diabetic nephropathy , hypertension , and even in the general population . |